On Wednesday (April 4), CannaRoyalty (CSE:CRZ,OTCQX:CNNRF) presented its financial results for Q4 2017, revealing a busy quarter of acquisitions in California.

CannaRoyalty acts as an investor of cannabis businesses in the available legal US market. As part of its quarterly report, the company revealed a revenue stream of C$1,072,399 was generated.


During its most recent quarter results, the company sought to acquire Alta Supply and River Distributions as a way to strengthen its distribution capabilities. CannaRoyalty also closed the acquisition of Kaya Management, the manufacturer of the “Bhang” vaporizer brand of products.

“We believe we are well positioned given our focus on the distribution side of things but creating an open and independent system,” Afzal Hasan, executive VP of corporate development said during a conference call.

CannaRoyalty determined it created C$3,077,969 worth of revenue for the entire business year, which split between four components: products, services, royalties, and interest. Royalties gathered the largest amount of revenue for CannaRoyalty, collecting C$1,103,645 during the year.

“Our market-leading distribution business places us in an ideal position to be a partner of choice for leading brands and dispensaries across the state,” CEO Marc Lusting said.

After the markets closed on Wednesday, the company’s Canadian stock rose 2.98 percent, reaching C$3.80 on the Canadian Securities Exchange (CSE). On Thursday (April 5) the company has continued its trend upwards, with a 0.26 percent increase after markets closed.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

CannaRoyalty exploring possibility of taking its brands outside of the US market

Lusting highlighted one of the more intriguing propositions by the company so far this year is the potential to bring its brand into jurisdictions outside the US and starting with Canada.

When the announcement was originally made of CannaRoyalty’s intentions to possibly bring its brands to Canada, Hasan told the Investing News Network (INN) the company had to secure a pathway for the distribution of its product before the regulations explicitly say about it.

Hasan also told INN the way for CannaRoyalty to enter the Canadian market could come via a licensing deal where another company pays a fee to bring the specific brands into the market.

Another option is for CannaRoyalty to downright acquire its own licensed producer (LP) or obtain a facility to get an LP status. It’s unclear what Canadian regulators would do regarding CannaRoyalty’s stance, given that on a federal level marijuana remains illegal in the US.

“Right now we are focused on building a platform in California to foster the creation of the global cannabis consumer product brands of the future,” Hasan said during the call.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

During the call Lusting said he is focused on five distinctive opportunities for CannaRoyalty in the cannabis space, including the integration of the company’s most recent acquisitions, continue its strategic acquisitions, set the fundamentals for the option to expand the reach of their brands into Canada and other jurisdictions, and a focus and rationalization of their portfolio.

During the question period of the call, Alan Brochstein, cannabis analyst with 420 Investor asked what the landscape was for more acquisitions in California.

Lusting answered by explaining there is a lot of opportunity for CannaRoyalty based on the fact that a lot of cannabis businesses remain unlicensed after the legalization of recreational cannabis this year.

“What that means is that there are a number of revenue streams in the market that did have a fair amount of that market share and consumer perception share as well that are up for sale right now,” he said.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced the Company will have senior management participating in the following virtual financial community conferences and events during December 2020 .

  • Roth Deer Valley Consumer Conference – December 9 th to 11 th , 2020
  • Cantor Fitzgerald 2020 Virtual Cannabis MSO Summit – December 15 th to 16 th , 2020
  • MKM Partners – The Road Ahead, Preparation for 2021 Conference – December 15 th to 16 th , 2020

For more information regarding upcoming Curaleaf financial community conference and event participation please visit the investor relations section of the company website, under the events tab, at https://ir.curaleaf.com/events .

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less